Riskpilot← Back to searchSign inGet full accessMAXIS LEGESENTER AS
ASActiveOrg 916523572Vesterveien 44, 4839 ArendalGeneral medical practice activities · NACE 8621Est. 20168 employees
Revenue 2024
NOK 4,4M
+4% vs 2023
EBITDA margin
9.0%
-33% vs 2023
Equity ratio
22.6%
Financial strength
Net profit 2024
NOK 293K
-44% vs 2023
| Revenue | NOK 4,4M | +4% |
| EBITDA | NOK 399K | -33% |
| Net profit | NOK 293K | -44% |
| Total assets | NOK 713K | +84% |
| Equity | NOK 161K | +222% |
| Employees | 8 | — |
Legal name
MAXIS LEGESENTER AS
Org number
916523572
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
7. januar 2016
Share capital
NOK 30 000
Employees
8 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg. Styrets leder alene. Daglig leder alene.
Company purpose
Drive medisinske og administrative servicefunksjoner i tilknytning til senterets leger.
Address
Vesterveien 44, 4839 Arendal
Phone
+4737012800
Email
post@maxislegesenter.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 444 | 2 818 | 3 236 | 4 272 | 4 443 |
| Staff expenses | −1 241 | −1 570 | −1 760 | −1 967 | −2 456 |
| EBITDA | 138 | −212 | −48 | 596 | 399 |
| Depreciation & amort. | −45 | −45 | −46 | −48 | −17 |
| EBIT | 93 | −257 | −94 | 549 | 382 |
| Net financials | −7 | −11 | −4 | −3 | −3 |
| Profit before tax | 87 | −268 | −98 | 546 | 379 |
| Tax | 50 | −0 | −31 | 27 | 86 |
| Net profit | 37 | −268 | −67 | 519 | 293 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 380 | 336 | 224 | 388 | 713 |
| Equity | −315 | −583 | −650 | −132 | 161 |
| Long-term debt | 311 | 307 | 270 | 0 | 0 |
| Short-term debt | 384 | 612 | 605 | 520 | 532 |
| Total debt | 695 | 919 | 875 | 520 | 552 |
EBITDA margin
9.0%
This company
15.8%
Market median
-43% vs market
20202024
Equity ratio
22.6%
This company
38.2%
Market median
-41% vs market
20202024
Return on equity
181.8%
This company
18.4%
Market median
+888% vs market
20202024
Net profit margin
6.6%
This company
8.1%
Market median
-19% vs market
20202024
Asset turnover
6.23×
This company
1.12×
Market median
+456% vs market
20202024
Debt / equity
3.42×
This company
0.62×
Market median
-452% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
HO Chief Executive Officer | Chief Executive Officer | 2023 |
| Former (1) | ||
NR Chief Executive Officer | Chief Executive Officer | 2020 – 2020 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 50% | 50% | 2024 | |
| Company | 50% | 50% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Lege Håvard Orlien As
MAXIS LEGESENTER AS Board members of MAXIS LEGESENTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nina Rasmussen Eikenes | Chief Executive Officer | 0 companies |
| Håvard Orlien | Chief Executive Officer | 0 companies |